Wednesday, July 23, 2014
YOLO COUNTY NEWS
99 CENTS

UCD vaccine fends off virus that strikes weak immune systems

By
From page A16 | November 03, 2013 |

SACRAMENTO — An experimental vaccine against human cytomegalovirus infection — which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system — proved safe and more effective than previous vaccines.

Developed by a team of scientists at UC Davis and the University of Alabama, Birmingham, the first-of-its-kind approach to preventing human CMV infection induced broader immunological protection in laboratory animals. The study will appear in the November issue of the Journal of Virology.

Development of a CMV vaccine has been ranked as the highest priority by the Institute of Medicine, an independent agency of the National Academy of Science, because of “the lives it would save and the disabilities it would prevent,” according to the U.S. Centers for Disease Control and Prevention.

“We’ve completed the first step in developing a vaccine to protect people against CMV by interfering with the virus’s attempts to enter and infect cells in the body,” said Peter Barry, a UCD professor of pathology and laboratory medicine and lead author of the study.

CMV is a type of herpes virus that is spread through close contact with the saliva, urine or other body fluids of a person infected with the virus.

Most CMV infections are not diagnosed because the virus typically causes few, if any, symptoms. As a result, most people infected are unaware that they harbor the virus — a condition that is of most concern among pregnant women, who are at risk for transmitting the virus to the fetus.

Children who are congenitally infected may have cognitive and other developmental disabilities, including hearing loss and blindness.

CMV is the most common viral cause of congenital defects in the United States. About one in 150 children in the U.S. is born with congenital CMV.

About one of every five children with congenital CMV infection — a total of 5,000 children each year — will develop hearing loss or developmental disabilities due to the infection, according to the Centers for Disease Control.

The virus also can infect animals, including rodents and rhesus macaque monkeys and other non-human primates. However, the species of the CMV found in animals differs from human and has not been reported to cause human disease.

Because so many previous vaccine approaches failed to provide complete protection against CMV infection, Barry and his collaborators adopted an “out-of-the-box” approach when designing the new vaccine.

They focused on the virus’s ability to gain a lifelong foothold in the body, a stage of the virus’s life cycle that no other research lab has targeted in research on potential vaccines.

“CMV is not like the influenza virus, which our immune systems can successfully clear from our bodies. CMV infection is persistent,” Barry said. “Once you’re infected, you’re always infected.”

The virus’ persistence and ability to infect individuals without creating obvious symptoms of infection help explain why CMV can be found in 50 to 80 percent of people under the age of 40.

The key to CMV’s persistence, Barry and his colleagues theorized, is interleukin-10 (IL-10): the master regulator of the immune system, which works to rein in an over-zealous immune response to an invading pathogen.

Barry previously discovered that early in its evolutionary history CMV hijacked IL-10 and incorporated its genes into the virus’s own DNA code.

As a result, CMV can manipulate the body’s normal immune response to the virus.

In developing their vaccine strategy, the researchers focused on neutralizing CMV’s own IL-10 so that the immune defense system was again capable of responding vigorously and effectively to the presence of the virus.

“We found that the animals did not become infected because, as a result of the vaccine, their immune systems generated neutralizing antibodies that prevented CMV from entering and infecting connective tissue cells, epithelial cells and other major cell types that the virus targets,” Barry said.

“The vaccine also created ‘immunological memory,’ which enables the immune system to respond quickly and effectively whenever CMV re-infection occurs.”

— UC Davis Health News Office

LEAVE A COMMENT

Discussion | No comments

The Davis Enterprise does not necessarily condone the comments here, nor does it review every post. Read our full policy

  • Recent Posts

  • Enter your email address to subscribe to this newspaper and receive notifications of new articles by email.

  • .

    News

     
    Second Mellon grant supports Mondavi events

    By Jeff Hudson | From Page: A1 | Gallery

    Are arachnids awesome or awful? Visit Bohart Museum to find out

    By Kathy Keatley Garvey | From Page: A1 | Gallery

     
    Police arrest suspect in robbery spree

    By Lauren Keene | From Page: A2

     
    Madhavi Sunder joins Davis school board race

    By Jeff Hudson | From Page: A2

     
    Crews make gains on massive Washington wildfire

    By The Associated Press | From Page: A2

    New safety rules proposed to curb oil train fires

    By The Associated Press | From Page: A2

     
    Kaiser awards grants to Yolo nonprofits

    By Special to The Enterprise | From Page: A3

     
    NAMI program offers mental illness information, support

    By Enterprise staff | From Page: A3

     
    Backpacks for Kids launches annual donation drive

    By Enterprise staff | From Page: A3

    Architecture in Davis, on ‘Davisville’

    By Enterprise staff | From Page: A3

     
    Speaker will spin some fishing tales at Davis meeting

    By Special to The Enterprise | From Page: A3 | Gallery

    Kids can paint their own Breyer horses at Davis store

    By Enterprise staff | From Page: A3

     
    Grandparents support group meets weekly

    By Enterprise staff | From Page: A3

    Exchange program seeks host families

    By Special to The Enterprise | From Page: A4

     
    Wine-tastings will benefit YCCC

    By Enterprise staff | From Page: A4

    Pedro party will benefit Yolo Hospice

    By Enterprise staff | From Page: A4

     
    Car lovers will speak Sunday at gallery

    By Enterprise staff | From Page: A4

    Racial diversity crucial to drug trials, treatments

    By San Francisco Chronicle | From Page: A4

     
    Enterprise is focus of Davis Roots talk

    By Enterprise staff | From Page: A5

    Quaff a beer and watch the bats

    By Enterprise staff | From Page: A5 | Gallery

     
    .

    Forum

    They’re pickier than she is

    By Creators Syndicate | From Page: B5

     
    U.S. is complicit in attack

    By Letters to the Editor | From Page: A6, 2 Comments

    Extinguish extremism for peace

    By Letters to the Editor | From Page: A6, 2 Comments

     
    With profound gratitude

    By Letters to the Editor | From Page: A6

     
    Someday, there will be peace

    By Rich Rifkin | From Page: A6

    Tom Meyer cartoon

    By Debbie Davis | From Page: A6

     
    .

    Sports

    Former Davis man at crossroads: biking or artwork?

    By Bruce Gallaudet | From Page: B1 | Gallery

     
    Aggie golfer headed to men’s U.S. Amateur Championship

    By Special to The Enterprise | From Page: B1 | Gallery

    Giants outlast Phillies

    By The Associated Press | From Page: B1 | Gallery

     
    River Cats nip dogs

    By Enterprise staff | From Page: B1

    A’s fall in extra innings

    By The Associated Press | From Page: B1 | Gallery

     
    Blue Jays hitting upends Red Sox

    By The Associated Press | From Page: B2

    Pyrenees please Nibali, Rogers in Tour Stage 16

    By The Associated Press | From Page: B3

     
    Albergotti to discuss Armstrong’s doping scandal

    By Bruce Gallaudet | From Page: B8

    .

    Features

    Field to Fork: Skyelark Ranch, not a lark at all

    By Dan Kennedy | From Page: A8 | Gallery

     
    Name droppers: ASUCD hands out awards

    By Enterprise staff | From Page: A8 | Gallery

    .

    Arts

    Tomato Festival makes call for young artists

    By Enterprise staff | From Page: A7

     
    Additional casting notice for ‘Hello Dolly’

    By Enterprise staff | From Page: A7

    Hear Los Tres de Winters on Thursday

    By Enterprise staff | From Page: A7

     
    Picott to play at The Palms Playhouse

    By Kate Laddish | From Page: A7

    Fairy-tale romance in Barnyard Theatre’s ‘Pinky’

    By Enterprise staff | From Page: A7

     
    Soar to Neverland with DMTC’s ‘Peter Pan’

    By Enterprise staff | From Page: A7 | Gallery

    Village Homes to host Rita Hosking Trio

    By Enterprise staff | From Page: A7 | Gallery

     
    .

    Business

    .

    Obituaries

    .

    Comics

    Comics: Wednesday, July 23, 2014

    By Creator | From Page: B6